Live data · NADAC + Part D CY24 · reviewed daily

Tenofovir Disoproxil Fumarate Tablets (TENOFOVIR DISOPROXIL FUMARATE)

First FDA approval2018-07-31
Generic availableNo (brand-only)
Shortage statusNone
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one
Lowest NADAC
$0.294/unit
1 NDCs benchmarked, lowest of all strengths.
Average NADAC
$0.294
Across all dosage forms in distribution.
Highest NADAC
$0.294
Range is tight.
Plans with PA
0 / 329
Zero PA friction across surveyed plans.

Questions a plan sponsor actually asks.

FAQPage schema7 entries indexed · 4 visible
What is Tenofovir Disoproxil Fumarate Tablets used for?

Tenofovir Disoproxil Fumarate Tablets is tracked in Medicare Part D. Specific indication information is not available in our current dataset.

Is there a generic for Tenofovir Disoproxil Fumarate Tablets?

No. Tenofovir Disoproxil Fumarate Tablets is brand-only with no generic equivalents currently in market.

How much does my plan pay for Tenofovir Disoproxil Fumarate Tablets?

Across 329 Part D plans, Tenofovir Disoproxil Fumarate Tablets averages $0.294/unit (NADAC). Lowest available: $0.294/unit. Highest in distribution: $0.294/unit.

Is Tenofovir Disoproxil Fumarate Tablets on the FDA shortage list?

No. Tenofovir Disoproxil Fumarate Tablets is not currently on the FDA Drug Shortage Database.

3 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Sources · every number above traces back.

Last refresh15 Oct 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book · NADAC unit costs: CMS NADAC weekly file (1 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.